Pfizer’s Mylotarg ... after the FDA reapproved it in the aggressive blood cancer, acute myeloid leukaemia. The world’s first approved antibody-drug conjugate, where a targeted antibody ...

the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just a few months later, the Pfizer treatment ...

M.D., deputy director of the Division of Non-Malignant Hematology in the FDA’s Center for Drug Evaluation and Research. “This new treatment option highlights our continued efforts to improve the lives ...

April 21, 2025 – The FDA just approved the popular drug Dupixent ... said in a news release from Sanofi, the drug's maker. Developed by Sanofi and Regeneron and first approved in 2017 ...

Related FDA approves new drug to treat protein buildup in the heart FDA approves first once-weekly drug treatment regimen for hemophilia ... At 1:30 p.m., Pfizer's stock was down 2 cents to ...

"Today's approval ... in the FDA's Center for Drug Evaluation and Research. "This new treatment option highlights our continued efforts to improve the lives of patients with hemophilia." ...